Literature DB >> 20965732

Contralateral femoral nerve compression: An unrecognized complication after extreme lateral interbody fusion (XLIF).

Ioannis D Papanastassiou1, Mohammad Eleraky, Frank D Vrionis.   

Abstract

Extreme lateral interbody fusion (XLIF) is a relatively new procedure for the treatment of degenerative disc disease avoiding the morbidity of anterior approaches. Ipsilateral L2-5 nerve root irritation and injury are well-described complications. We describe two patients with contralateral extremity symptoms, not reported so far. In the first patient the injury was caused by a displaced endplate fragment compressing the contralateral nerve root; in the second patient, the injury resulted from a far-lateral herniation after the XLIF procedure. Both patients experienced resolution of their symptoms after being reoperated. Overall, this complication was encountered in 2/32 levels treated during the study period. Overzealous endplate removal and breaking of the osteophytes in the opposite corner of the intervertebral disc, although desirable for maximal coronal deformity correction, may lead to irritation of the contralateral nerve roots. Attention is needed especially where the interbody cage is placed posteriorly or diagonally towards the neuralforamen. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20965732     DOI: 10.1016/j.jocn.2010.07.109

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  14 in total

1.  Multimodality intraoperative neuromonitoring in extreme lateral interbody fusion. Transcranial electrical stimulation as indispensable rearview.

Authors:  Hanneke I Berends; Henricus L Journée; Ilona Rácz; Jan van Loon; Roger Härtl; Maarten Spruit
Journal:  Eur Spine J       Date:  2015-08-27       Impact factor: 3.134

Review 2.  MIS lateral spine surgery: a systematic literature review of complications, outcomes, and economics.

Authors:  Jeff A Lehmen; Edward J Gerber
Journal:  Eur Spine J       Date:  2015-04-08       Impact factor: 3.134

3.  Extreme lateral interbody fusion in spinal revision surgery: clinical results and complications.

Authors:  Matteo Formica; Andrea Zanirato; Luca Cavagnaro; Marco Basso; Stefano Divano; Lamberto Felli; Carlo Formica
Journal:  Eur Spine J       Date:  2017-05-09       Impact factor: 3.134

Review 4.  Comparison of the safety outcomes between two surgical approaches for anterior lumbar fusion surgery: anterior lumbar interbody fusion (ALIF) and extreme lateral interbody fusion (ELIF).

Authors:  Roger Härtl; Alexander Joeris; Robert A McGuire
Journal:  Eur Spine J       Date:  2016-03-17       Impact factor: 3.134

5.  Neurologic deficit following lateral lumbar interbody fusion.

Authors:  Matthias Pumberger; Alexander P Hughes; Russel R Huang; Andrew A Sama; Frank P Cammisa; Federico P Girardi
Journal:  Eur Spine J       Date:  2011-12-01       Impact factor: 3.134

6.  Lumbar artery branches coursing vertically over the intervertebral discs of the lower lumbar spine: an anatomic study.

Authors:  Hidetoshi Nojiri; Kei Miyagawa; Sammy Banno; Ikko Sakamoto; Masato Koike; Mamiko Sawa; Yoshiyuki Iwase; Hiroyuki Kudo; Tatsuo Sakai; Kazuo Kaneko
Journal:  Eur Spine J       Date:  2016-08-06       Impact factor: 3.134

7.  High neurological complication rates for extreme lateral lumbar interbody fusion and related techniques: A review of safety concerns.

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2016-09-22

8.  One-stage extreme lateral interbody fusion and percutaneous pedicle screw fixation in lumbar spine tuberculosis.

Authors:  Q-Y Wang; M-G Huang; D-Q Ou; Y-C Xu; J-W Dong; H-D Yin; W Chen; L-M Rong
Journal:  J Musculoskelet Neuronal Interact       Date:  2017-03-01       Impact factor: 2.041

9.  The lateral transpsoas approach to the lumbar and thoracic spine: A review.

Authors:  Paul M Arnold; Karen K Anderson; Robert A McGuire
Journal:  Surg Neurol Int       Date:  2012-07-17

10.  Evaluation of lumbar fusion using the anterior to psoas approach for the treatment of L5/S1 spondylolisthesis.

Authors:  Wei He; Da He; Wei Tian
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.